Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:1020-1023 (30 October), doi:10.1136/bmj.329.7473.1020
Diana Lockwood, consultant physician1, Margaret Armstrong, research coordinator1, Alison Grant, consultant physician1
1 Hospital for Tropical Diseases, University College London Hospitals NHS Trust, Mortimer Market Centre, London WC1E 6AU
Correspondence to: A Grant alison.grant{at}lshtm.ac.uk
Strategy for change Routine EBM meetings introduced in 1997.
Design Review of outcomes of meetings from 1997 to 2004, focusing on their effect on clinical practice.
Setting Referral centre for tropical and domestic infectious diseases.
Key measure for improvement Outcome of meetings, classified as resulting in a change in practice; confirmation or clarification of existing practice; identification of a need for more evidence; and outcome unclear.
Effects of change Examples include a change from inpatient to day case treatment of New World cutaneous leishmaniasis; development of guidelines on the treatment of coinfection with visceral leishmaniasis and HIV; and identification of the need for more data on the efficacy and toxicity of atovaquone-proguanil (Malarone) compared with quinine plus sulfadoxine-pyrimethamine (Fansidar) in the treatment of uncomplicated falciparum malaria, which resulted in a clinical trial being set up.
Lessons learnt Incorporation of EBM meetings into our routine practice has resulted in treatment guidelines being more closely based on published evidence and improvements to care of patients. Written summaries of the meetings are important to facilitate change.
The process of EBM
We aim to have one EBM meeting every two months, each lasting two hours over a Friday lunchtime. The meeting chairperson is allocated by rotation among the consultants and specialist registrars, though any team member who wants to investigate a particular clinical question can lobby to chair the next available meeting. The chairperson chooses the question to be addressed, identifies articles to be reviewed, and distributes these articles among the members of staff who will attend the meeting, aiming for each person to be allocated one or two articles. Those given articles review them in detail beforehand, then present the key points from each paper at the meeting. We have produced notes to help the chairperson prepare for the meeting (see box), and for reviewers, giving guidance on critical appraisal and references to key EBM texts (see further details on bmj.com). Outside experts may be invited if this will facilitate discussion.
At the meeting the selected papers are presented in an order determined by the chairperson. After each paper we take points of clarification, but the main discussion is deferred until the end, when we try to reach consensus about the evidence presented. After the meeting, the chairperson writes a summary that is circulated to all medical staff and stored on our intranet and in the library, along with a copy of the papers presented. Our clinical guidelines are updated if appropriate.
|
|
Meetings resulting in a change in practice
Until 2002 we treated patients with New World cutaneous leishmaniasis as inpatients with 21 days of intravenous sodium stibogluconate. In an EBM meeting we reviewed published data on the toxicity of sodium stibogluconate and concluded that serious cardiac toxicity is rare and predictable, patients with pre-existing cardiac disease and elderly patients being at higher risk. An audit of toxicity among our patients confirmed this view, and sodium stibogluconate treatment is now given on a day case basis to young patients with no pre-existing heart disease by using an integrated care pathway developed with our nursing team.
Meetings identifying the need for more evidence
We reviewed the evidence concerning atovaquone-proguanil (Malarone) as a treatment for uncomplicated falciparum malaria. We concluded there were insufficient data to justify changing our current first line regimen from quinine plus sulfadoxine-pyrimethamine to atovaquone-proguanil and have set up a randomised controlled trial to compare the efficacy and toxicity of these two regimens.
Share out the role of meeting chairpersonThe chair has a key role in the success of the meeting. Important tasks include refining the question to be addressed so that it is not too broad or too narrow; doing an effective literature search; deciding which articles should be presented in the meeting; allocating each article to an appropriate person (it may be better to give more complex articles to people with more experience in literature appraisal); and writing a summary of the meeting. This is time consuming (perhaps two days' work in total), and we rotate this role so that it is not too onerous for any one individual. The chairperson needs to identify appropriate literature to review; library staff may be able to advise on literature search strategies. Having team members trained in critical appraisal is helpful.
Include key people involved in making practice guidelinesIf the question has implications for current guidelines, we make sure that key people involved in decision making attend the meeting. For example, if the question concerns whether or not a particular diagnostic test should be done, a senior staff member from the laboratory concerned should be invited to take part.
Involve staff at all levelsAll members of staff attending our meetings are given at least one article to review and present. Guidelines for presenters help to ensure that people with less experience of literature appraisal focus on the key issues.
Ensure there is enough time to discuss the evidenceIt is crucial that there is enough time to discuss the evidence presented. There may be questions or discussion about individual articles. More importantly, there must be enough discussion time at the end to reach consensus as to whether practice should be changed. This may mean restricting the selection of papers that are reviewed in the meeting to those which are most relevant. Presenters must also keep strictly to time: it may help to appoint a timekeeper.
Consider appointing a scribeIf there are many articles to review, it may help to have someone to write the main findings and conclusions of each study on a white board or flip chart. This generates a summary of the evidence presented, which assists discussion at the end.
Chase the chairperson for a summary of the meetingMeetings for which the chairperson does not produce a written summary for the records are unlikely to result in a change in practice.
|
To date, the issues examined have generally been about clinical diagnosis and treatment and have primarily involved medical staff, with contributions from colleagues in the laboratory disciplines and pharmacists to discuss specific questions. In the future we would like to make more meetings multidisciplinary.
Overall, we have found EBM meetings a good way to bring together all members of the team in a way that builds consensus around practice guidelines and helps to ensure that our guidelines evolve to incorporate new evidence.
Contributors: DNJL established and has overseen the EBM sessions since 1997. MA manages the EBM database. ADG had the idea for the article, which was further developed by DNJL and MA. ADG and DL wrote the paper. All authors approved the final paper. ADG is guarantor.
Funding: MA is supported by the Special Trustees of the Hospital for Tropical Diseases. ADG is supported by a National Public Health Career Scientist award from the Department of Health.
Competing interests: None declared.
Ethical approval: Not required.
(Accepted 4 August 2004)
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+